Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Medicare Advantage markets are highly concentrated across the country, according to a new study from KFF. | Medicare ...

The news comes weeks after a cohort of top health insurers agreed to adjust the controversial preapproval process that can ...

Discover why UNH is undervalued despite profitability pressures and how analysts project a return to strong growth by 2026.

Humana is taking a second bite at the apple to improve its sunken MA stars, filing an edited complaint with a Texas court on ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the ...

Health insurer Humana is scaling back the number of medical services subject to prior approval and speeding up decisions ...

Sarepta's pause on its prescription gene therapy drug for Duchenne muscular dystrophy gives the company time to work with the FDA on reviews. Infusions nationwide will be canceled. Also in the news, ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

Humana Inc., a leading health and well-being company, today announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by January 1, 2026.

Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...